Celularity
Latest round
- Series B
Last raised
- Feb 2018
Total raised
- $250M
Investors
- 8
About Celularity
Based in New Jersey, US, and founded in 2016, Celularity, Inc. develops transformative allogeneic cellular therapies. The company was co-founded by Peter Diamandis and Robert Hariri, it's Chairman and CEO. In March 2023, Celularity, Inc. The company develops placenta-derived allogeneic cell therapies for cancer, infectious, and degenerative diseases. Celularity's product targets multiple diseases, and provides seamless integration, from bio-sourcing through manufacturing cryopreserved and packaged allogeneic cells.
Who invested in Celularity
8 investors across 1 round
See all investors in Celularity
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 15, 2018
Amount
$250M
Investors
Questions about Celularity
Who invested in Celularity?
Celularity has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Celularity raised?
Celularity has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Celularity last raise money?
Celularity's most recent round on record is a Series B, in Feb 2018.
What does Celularity do?
Based in New Jersey, US, and founded in 2016, Celularity, Inc.
Where is Celularity headquartered?
Celularity is headquartered in Florham Park, US.
Which VCs invest in companies like Celularity?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Celularity's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Celularity? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.